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ABSTRACT 
 
Aims: H. pylori infection is associated with gastritis, pre cancerous lesions, gastric cancer and 
changes in the protective layer of mucus. However, to our knowledge, there are no studies in 
humans or experimental models that relate the infection with H. pylori strains containing one or 
three phosphorylation sites of the CagA protein with the mucins of the protective layer of mucus. 
The aim of this study was to research the effects of infection with H. pylori strains containing one or 
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three phosphorylation sites of CagA protein on the MUC1 and MUC5AC mucins of Mongolian 
gerbils (Meriones unguiculatus) gastric mucosa.  
Methods: Mongolian gerbils were inoculated with H. pylori isolates containing one or three EPIYA 
C phosphorylation sites. The control group consisted of uninfected animals receiving only Brucella 
broth. Gastric mucosa fragments were assessed by immunohistochemistry using rabbit monoclonal 
antibodies against MUC1 and MUC5AC. The fragments were then analyzed through a digital 
morphometric method.  
Results: From the control group of non-infected animals (CTRL) to the Cag A positive locci with 1 
EPYIA C group (CagA1Ep) and Cag A positive locci with 3 EPYIA C group (CagA3EP) there was a 
progressive and significant reduction in the expression of both MUC1 (p=0.003) and MUC5AC 
(p=0.003) after 45 days of infection. This reduction was more prominent in the CagA3Ep group. 
Similar results were obtained six months post-infection, but the reduction in the MUC5AC (p=0.001) 
and MUC1 (p=0.001) expression was more intense. 
Conclusion: H. pylori strains containing more phosphorylation sites of the CagA protein are able to 
reduce with greater intensity the expression of MUC1 and MUC5AC.  
 
 
Keywords: Helicobacter pylori; Mucin-1; Mucin-5AC; CagA protein. 
 
1. INTRODUCTION 
 
Mucins are high molecular weight glycoproteins 
synthesized by various secretory epithelial cells. 
In a normal human gastric mucosa the produced 
mucins include MUC1, MUC5AC and MUC6. The 
membrane-associated MUC1 is produced by 
foveolar cells and to a lesser extent, by the 
mucosal glands. The MUC5AC mucin is secreted 
only by the foveola epithelium cells and it is the 
primary constituent of the gel surface layer. The 
secretion of MUC6 is limited to the mucous 
glands [1]. 
 
H. pylori is mainly found in the gastric layer of 
mucus, and rarely colonizes the lower portions of 
the gastric mucosa [2]. It is well documented by 
some authors that patients infected with H. pylori, 
present a decreased amount of polymeric mucin 
on the surface of the gastric mucosa, with 
subsequent weakening of mucus layer firmly 
adhered to the surface [3]. Furthermore, in 
chronic gastritis the epithelial surface shows 
degenerative changes with loss of mucins and 
increased cell exfoliation [4]. Moreover, the 
different degrees of gastric diseases caused by 
H. pylori are closely related to their genetic 
background and their polymorphism index [5,6]. 
The main difference in the gene content of the 
different strains of H. pylori is the presence or 
absence of a 40 kb locus, called Cag PAID (Cag 
pathogenicity island), which is present in H. pylori 
strains distributed in different parts of the world 
[7-9]. This locus is composed by about 27 to 31 
genes, among these, is the Cag 26 gene, which 
encodes a highly pathogenic protein called 
CagA; and the genes Cag7, Cag10 and Cag12, 
which encode a secretion factor type IV (T4SS) 
that translocates CagA into the interior of the 
gastric epithelial cells [10]. 
 
The virulence of some H. pylori strains is 
increased due to the phosphorylation of tyrosine 
residues of a sequence of five repeated amino 
acids, located in the carboxyl terminal portion              
of the CagA protein, called EPIYA. The 
polymorphism in this region involves changes in 
the sequence of repeated amino acids resulting 
in modified EPIYA A, B, C and D [5,11]. Thus,          
H. pylori strains with more number of EPIYAS 
have a higher degree of CagA phosphorylation, 
and therefore are associated with more severe 
chronic gastritis and the emergence of intestinal 
metaplasia and gastric cancer in humans [12]. 
Recently, we found that Mongolian gerbils 
infected with H. pylori strains containing three 
EPIYA-C sites developed a more intense  
chronic gastritis and changes in the numbers of 
G and D cells, as observed in human disease 
[13,14]. 
 
Some papers relate mucin content with H. pylori 
infection, both in humans and experimental 
models [15-17]. However, there is no study 
relating the content of specific mucins to infection 
by strains of CagA positive H. pylori with more 
than one phosphorylation site. To our knowledge, 
there are no studies quantitatively evaluating the 
expression of MUC1 and MUC5AC in healthy 
Mongolian gerbils. Thus, the aim of this research 
was to evaluate the immunohistochemical 
expression of MUC1 and MUC5AC mucins in 
Mongolian gerbils, which were healthy or infected 
by H. pylori strains containing one or three CagA 
EPIYA C phosphorylation sites, by a digital 
morphometric method. 
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2. MATERIALS AND METHODS 
 
2.1 Animals, Experimental Design and 
Inoculation of H. pylori 
 
The animals were kept under natural ventilation 
and mechanical exhaust, subjected to natural 
day and night cycles, with free access to filtered 
water and standard rat chow (Labina®, Purina, 
Brazil) and handled in accordance to the Ethics 
Committee on Animal Experimentation of the 
Federal University of Minas Gerais (CEUA-
UFMG). 
 
The animals were divided into three groups: a 
control group of non-infected animals (CTRL), a 
Cag A positive locci with 1 EPYIA C (CagA1Ep) 
group and Cag A positive locci with 3 EPYIAS C 
(CagA3Ep) group. Each group consisted of 16 
animals. Eight of these animals were euthanized 
45 days after the infection, and the remaining 8 
after 6 months of the infection. The animals of 
this research were used in two previous studies 
[13,14]. Prior to inoculation, the animals were 
fasted for eight hours and lightly sedated with 
Isoflurane (Abbott, São Paulo, SP, Brazil). The 
inoculum of 0.8 ml of bacterial suspension 
containing 109 CFU / ml in sterile Brucella broth 
or only Brucella broth (CTRL group) was 
administered by intragastric gavage three times 
at 48 hour intervals. Four hours after inoculation, 
the animals were given standard rat chow 
(Labina®, purine, Brazil) and water ad libitum. 
Further details about the isolation of HP lines, 
DNA extraction and sequencing can be obtained 
in our previous study [13].  
 
2.2 Necropsy and Immunohistochemical 
Reactions to MUC1 and MUC5AC 
 
An abdominal incision was made, the stomach 
removed and opened along the greater curvature 
and the mucosa of the gastric body and antrum 
were exposed. Then the stomach was distended, 
washed with saline solution and the antral 
fragments of approximately 2.0 x 0.5 centimeters 
were collected along the small and large 
curvature to histological processing. Then, these 
fragments were fixed in 10% buffered formalin for 
a period of 48 hours. After this procedure, the 
fragments were dehydrated, diaphanized, 
infiltrated, and embedded in paraffin and sections 
of 4 micrometers thick were obtained for      
staining and immunohistochemical reactions. 
The sections were deparaffinized and hydrated in 
alcoholic solutions of decreasing concentrations 
and washed in phosphate buffered saline (PBS) 
pH 7.2. Antigenic recovery was performed with 
Dako Retrieval Solution (Dako, USA) at 100°C 
for twenty minutes for both MUC1 and MUC5AC 
producing cells. The endogenous peroxidase 
activity was supressed by incubating the sections 
in a solution containing 3.5% H2O2 (30vv) in 200 
ml of PBS solution for twenty minutes, and the 
nonspecific binding sites were blocked by 
incubating sections with diluted goat serum 
(1:40) for forty minutes. For the identification of 
MUC1 and MUC5AC mucins, anti-MUC 1 and 
anti-MUC5AC monoclonal primary antibodies 
were used (Santa Cruz Biotechnology, Santa 
Cruz, USA. VU4H5 and H-160 clones, 
respectively) diluted in 0.1% BSA solution at 
concentration of 1:80. Subsequently, goat anti-
mouse and goat anti-rabbit secondary antibodies 
for MUC5AC and MUC1(dilution, 1:50) were 
respectively used for one hour at room 
temperature. The stain was detected using a 
solution containing 0.05% diaminobenzidine in 
0.2% H2O2 (40 v/v) for three minutes. As a 
negative control, the primary antibody was 
replaced with PBS in some antral sections of 
control gerbils. Histological antral sections of 
control gerbils were also used as positive 
controls. The sections were counterstained with 
Harris hematoxylin (diluted in distilled water to 
60%) and mounted in entelan. 
 
2.3 Morphometric Analysis of 
Immunohistochemical Expression of 
MUC1 and MUC5AC 
 
For evaluation of MUC1 and MUC5AC 
expression, the area of immunohistochemical 
staining in the antral mucosa of all animals of the 
CTRL, CagA1EP and CagA3EP groups was 
measured in both periods of infection. A total 
area of 9x10
5
 µm
2 
of the antral mucosa was 
scanned by a microcamera Q-Color3 (Olympus, 
Tokyo, Japan) for each animal. The area was 
calculated with the use of algorithms sequences 
built in the KS300 software coupled to a Carl 
Zeiss image analyzer (Oberkochen, Germany) 
[18]. Through the segmentation of images all 
brown pixels related to immunohistochemical 
markers were selected for creation of binary 
images and the subsequent calculation of the 
area (μm
2
). The MUC1 and MUC5AC positive 
area of the control animals was considered                   
as a normal expression pattern of these                  
mucins in healthy Mongolian gerbils. The                    
data were compared among the different                
groups and periods of infection by the two           
tailed Mann-Whitney U test (GraphPad Prisma 
6.01).  
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3. RESULTS 
 
A brown cytoplasmic staining in the                   
gastric epithelial cells identified positive 
immunohistochemical reactivity for both MUC1 
and MUC5AC. Positive immunoreactive cells for 
MUC5AC were located predominantly in the 
apical portion of the foveolar epithelium and in 
the basal portion of the glands, usually showing a 
less intense stain between the two portions,         
with regions of negative marking. The MUC1-
producing cells were found throughout the entire 
mucosal thickness, but usually with a lower 
marking intensity than MUC5AC mucin (Figs. 1a, 
b). The omission of the two primary antibodies 
did not produce a positive immunohistochemical 
reaction (Figs. 1c, d).  
 
After 45 days of infection, there was a significant 
decrease in both MUC1 and MUC5AC 
expression in the CagA1Ep group (MUC1: 
209,761 ± 13,740 µm
2
; MUC5AC: 326,888 ± 
11.298 µm2) (p=0.003) and CagA3EP group 
(MUC1: 76,599 ± 16,709 µm
2
; MUC5AC: 97,358 
± 18,724 µm
2
) (p=0.003) when compared to the 
control group (MUC1: 322,024 ± 15,137 µm2; 
MUC5AC: 424,140 ± 13,423 µm
2
). This reduction 
was more prominent in the CagA3Ep group 
(p=0.003) (Figs. 2 a,b,c,d and 3a).  
 
After six months of infection, there was also a 
significant decrease in MUC1 and MUC5AC 
expression in the CagA1Ep group (MUC1: 
110,296 ± 9,667 µm2; MUC5AC: 164,447 ± 8,111 
µm
2
) (p=0,001) and CagA 3Ep group (MUC1: 
30,153 ± 7,972 µm2; MUC5AC: 38,844 ± 8,714 
µm
2
) (p=0.001) when compared to the control 
group (MUC1: 288,529 ± 16,137 µm
2
; MUC5AC: 
441,149 ± 36,353 µm2). The decrease was more 
pronounced in CagA3Ep group than in the 
CagA1Ep group (p=0.001) (Figs. 2e,f,g,h and 
3b). 
 
Comparing the infected animals that were 
euthanized 45 days post-infection to the infected 
animals that were euthanized six months post-
infection, there was a reduction in the expression 
of both MUC1 (p=0,001, for both groups) and 
MUC5AC (p=0.03 and p=0.02 for CagA1Ep and 
CagA3Ep groups, respectively). No significant 
changes were observed between the CTRL 
groups in the two analyzed periods (p = 0.20 and 
p = 0.33 for MUC5AC and MUC1, respectively). 
 
 
 
Fig. 1. Immunohistochemical reaction for MUC1 and MUC5AC mucins in the antral mucosa of 
the control group gerbils. Muscularis mucosa (*). (a) Positive reaction for MUC1 (arrowheads); 
(b) Positive reaction for MUC5AC (arrowheads); (c) Negative control to immunohistochemical 
reaction for MUC1; (d) Negative control to MUC5AC immunohistochemical reaction. Counter-
staining with Harris hematoxylin. Scale bar: 50 micrometers 
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Fig. 2. Photomicrographs of immunohistochemical reactions for MUC1 and MUC5AC mucins in 
antral mucosa of gerbils infected with CagA positive Helicobacter pylori, with one or three 
EPIYA-C segments. Muscularis mucosa (*). (a) Positive reaction for MUC1 (arrowheads) - 
CagA1Ep group - 45 days of infection; (b) Positive reaction for MUC5AC (arrowheads) - 
CagA1Ep group - 45 days of infection; (c) Positive reaction for MUC1 (arrowheads) - CagA3Ep 
group - 45 days of infection; (d) Positive reaction for MUC5AC (arrowheads) -CagA3Ep group - 
45 days of infection; (e) Positive reaction for MUC1 (arrowheads) - CagA1Ep group - six 
months of infection; (f) Positive reaction for MUC5AC (arrowheads)  - CagA1Ep group - six 
months of infection; (g) Positive reaction for MUC1 (arrowheads) - CagA3Ep group - six 
months of infection; (h) Positive reaction for MUC5AC (arrowheads) - CagA3Ep group - six 
months of infection. Counter-staining with Harris hematoxylin. Scale bar: 50 m 
Fig. 3. MUC1 and MUC5AC areas of the antral gastric mucosa of gerbils infected with 
strains producing CagA protein, containing one or three 
non-infected animals after 45 days (a) or six months (b) post infection
eight animals. The upper and lower boundaries of the boxes repres
and 25%, respectively. The horizontal line throughout the box shows the median and the filled 
boxes indicate the maximum and minimum data value. 
 
4. DISCUSSION 
 
Several authors have demonstrated that infection 
by H. pylori interferes with the gastric mucin 
content [15,17,19]. However, this is the first study 
to demonstrate reduction in the gastric mucin 
expression of gerbils infected with CagA positive
H. pylori strains containing one or three 
phosphorylation sites using an accurate 
morphometric digital method.  
 
When H. pylori was still known as Campylobacter 
pyloridis, it was found that infection with this 
bacterium is able to interfere with t
mucus layer, leading to its reduction [20]. 
However, the mechanisms involved in these 
alterations are not fully understood and there is 
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EPIYA-C phosphorilation sites, and of 
. Each group consists of 
ent the percentage of 75% 
Data were analyzed by the two
Mann-Whitney U test 
 
EPIYA C 
he gastric 
no consensus about the results obtained for the 
probable alterations in the gastric mucins 
composition [21].  
 
In our study H. pylori isogenic strains isolated 
from a single patient with gastric cancer were 
used. We observed a reduction in the expression 
of two gastric mucins during different periods of 
infection. From the CTRL group to the CagA1Ep 
and CagA3EP groups there was a progressive 
and significant reduction in the expression of 
both MUC1 and MUC5AC after 45 days of 
infection. This reduction was more prominent in 
CagA3Ep group. Similar results were obtained 
six months post-infection, but the reduction of t
MUC5AC and MUC1 expression was more 
intense. The findings about the reduction of 
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mucins associated with H. pylori infection are 
supported by the work of other authors 
[4,14,17,19]. Navabi et al. [19] showed a 
reduction in the MUC1 production and a 
decreasing trend in the production of MUC5AC of 
the gastric antrum of mice infected with H. pylori 
[19]. The reduction of MUC5AC expression was 
also progressively higher in human advanced 
gastric carcinoma when compared to metaplasia 
and dysplasia, suggesting that mucin alterations 
could be considered as markers of the gastric 
mucosa malignant transformation [16]. Also in 
mice infected with Helicobacter felis, it was 
observed a loss of MUC5AC, which was 
correlated with gastritis and occurred before the 
onset of atrophy and intestinal metaplasia [20]. 
 
H. pylori seems to interfere in the MUC1 and 
MUC5AC glycosylation process, favoring the 
interaction of bacterial adhesins with the gastric 
epithelial surface and contributing with the 
bacteria colonization [17]. Furthermore, H. pylori 
releases urease, which degrades urea and 
releases ammonia, raising the gastric pH. This 
increase in pH results in a decrease in the mucus 
layer viscoelasticity making it more fluid, which 
facilitates the mobility of the bacteria through this 
layer and its adhesion to gastric epithelial cells 
[21]. The VacA cytotoxin is another product of   
H. pylori that is involved in the mucin reduction. 
Beil et al. [20] demonstrated that positive CagA 
H. pylori strains that produce vacA cytotoxin 
caused a significant inhibition of the mucin 
synthesis when compared to cagA positive 
strains that do not produce this toxin. Negative 
CagA strains did not interfered in the mucin 
synthesis.  
 
Besides the bacterial inherent factors, 
inflammatory phenomena seem to be 
significantly involved in the reduction of gastric 
mucin. In chronic gastritis caused by H. pylori, 
the epithelium surface shows degenerative 
changes with loss of mucins and increased cell 
exfoliation. These degenerative changes are 
sometimes accompanied by atrophy, while the 
lamina propria becomes edematous and with the 
presence of inflammatory cells [4]. Neutrophilic 
proteases released during gastritis caused by          
H. pylori may contribute to the collapse of the 
mucins structure [3].  
 
Some studies evaluated the possibility of 
different cytokine profiles produced during           
H. pylori infection to interfere with mucin 
expression. IL-1β as well as IL-6 were able to 
increase the gastric mucin expression of 
epithelial cells in vitro, whereas IFN-γ potentiated 
the inhibitory effect of the H. pylori lysate [22]. 
Different authors have observed that H. pylori 
infection induces a prominent IFN-γ synthesis, 
with significant increase in the number of T cells 
positive for this cytokine [23,24]. Besides 
bacterial inherent factors, a higher concentration 
of IFN- could act as a helping factor in mucin 
reduction. 
 
Some authors have shown that infection of 
humans with H. pylori CagA positive strains 
containing a high number of EPIYA C 
phosphorylation sites is associated with more 
severe chronic gastritis and an increased risk of 
developing intestinal metaplasia and gastric 
cancer [25,26]. Our group has recently 
demonstrated that Mongolian gerbils infected 
with H. pylori strains containing three EPIYA-C 
sites have a more intense gastric inflammation 
than the animals infected with strains containing 
only one EPIYA-C site [13]. It is known that the 
most virulent strains contain Cag PAI (cag 
pathogenicity island), responsible for encoding 
the T4SS. When the CagA protein is injected 
inside the gastric epithelial cell through T4SS, 
the protein is phosphorylated on its tyrosine 
residues located in a region of five repeated 
amino acids named EPIYA (Glu, Pro, Ile, Tyr, 
and Ala) A, B, C and D located in its carboxy-
terminal portion. The CagA phosphorylation 
results in a bond with a protein tyrosine 
phosphatase SHP2. This CagA-SHP2 complex 
activates intracellular protein kinases of the 
MAPK family, the ERK1 / 2, inducing 
transcription of proinflammatory, anti-apoptotic 
and mitogenic genes [27,28]. Furthermore, the 
more intense CagA phosphorylation, the greater 
its binding force with protein SHP2 [29]. Thus, it 
is believed that the greater the number of EPIYA 
phosphorylation sites of CagA, the greater will be 
the inflammatory cytokines activation, resulting in 
a more exuberant inflammatory response. In fact, 
animals experimentally infected with H. pylori 
containing EPIYA C with 3 phosphorylation sites, 
produced a more intense gastritis than the 
CagA1Ep group [13].  
 
From the Ctrl groups to the CagA1Ep and 
CagA3Ep groups it was possible to demonstrate 
a significant and progressive reduction in the 
MUC1 and MUC5AC contents in both periods of 
infection. This can be attributed to the influence 
of bacterial toxicity factors that interfere with 
MUC1 and MUC5AC synthesis and also to the 
inflammatory process. These findings are of 
great scientific and clinical relevance, since it 
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was demonstrated that H. pylori strains 
containing more phosphorylation sites of CagA 
induces a greater decrease in one of the gastric 
mucosa major defense barriers, predisposing a 
higher contact with toxic substances and 
pathogens, favoring a more severe gastritis and 
the appearance of precancerous lesions and 
gastric cancer. However, further work will be 
necessary to evaluate the effect of reducing the 
expression of MUC1 and MUC5AC in the 
development of precancerous and neoplastic 
lesions caused by H. pylori for a longer period of 
infection.  
 
We concluded that H. pylori strains containing 
more Epiya-C phosphorylation sites of CagA 
induce a greater decrease of MUC1 and 
MUC5AC in Mongolian gerbils gastric mucosa 
than strains containing less phosphorylation 
sites. 
 
5. CONCLUSION  
 
H. pylori strains containing more phosphorylation 
sites of the CagA protein are able to reduce with 
greater intensity the expression of MUC1 and 
MUC5AC.  
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